Company Quick10K Filing
nDivision
10-Q 2021-03-31 Filed 2021-05-14
S-1 2021-03-09 Public Filing
10-K 2020-12-31 Filed 2021-03-30
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-12
10-K 2019-12-31 Filed 2020-03-25
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-Q 2017-12-31 Filed 2018-02-06
10-K 2017-09-30 Filed 2017-12-20
10-Q 2017-06-30 Filed 2017-08-03
10-Q 2017-03-31 Filed 2017-05-03
10-Q 2016-12-31 Filed 2017-02-01
10-K 2016-09-30 Filed 2016-12-28
8-K 2020-10-13
8-K 2020-09-28
8-K 2020-09-24
8-K 2020-09-08
8-K 2020-09-04
8-K 2020-08-18
8-K 2020-05-04
8-K 2020-04-07
8-K 2019-10-22
8-K 2019-10-18
8-K 2019-10-15
8-K 2019-08-12
8-K 2019-05-22
8-K 2019-05-16
8-K 2019-04-16
8-K 2019-04-03
8-K 2019-04-01
8-K 2019-03-15
8-K 2019-03-06
8-K 2019-01-10
8-K 2018-12-06
8-K 2018-03-14
8-K 2018-02-26
8-K 2018-02-13
8-K 2018-02-12

nDivision Financials

NDVN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2527216111,1002805215591140177
Accounts Receivable100110172336502478618696602
Inventory
PP&E3,0862,1022,1022,0912,1431,9611,629
Assets2627217213,2342,4272,1852,0642,0891,959
Accounts Payable106139113941329738131
Long-Term Debt24613713737784429
Liabilities10710216291,6171,4031,4461,4731,5111,5531,573
Stockholders' Equity1619115-13-281,6171,024738591578593386
Income Statement ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue877938131,8841,1421,4561,3851,416
Cost of Revenue43442314255270276262302
Gross Profit444524991,3168721,1801,1231,114
R&D
SG&A7341921,2252,7141,3651,3571,4511,452
Tax0000000000
Net Income-11-8-6-18-15-744-694-517-165-342-357
Cash Flow ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-13-6-15-14-8-727-1,505-3701084111
Cash Investing-811-290-2-33-9
Cash Financing14001082,5102,497141-17078-65